NCT04842162View on ClinicalTrials.gov

Study Evaluating Near-infrared Imaging Coupled With Indocyanine Green for Intraoperative Control of Resection Margins in ENT Surgery

PHASE2RecruitingINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

December 15, 2020

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2026

Conditions
Head and Neck Cancer
Interventions
DRUG

indocyanine green

indocyanine green (INFRACYANINE© 25mg/10mL).

Trial Locations (2)

1070

RECRUITING

Institut Jules Bordet, Anderlecht

94800

RECRUITING

Gustave Roussy, Villejuif

All Listed Sponsors
lead

Gustave Roussy, Cancer Campus, Grand Paris

OTHER